Collegium Pharmaceutical, Inc. (COLL)

USD 26.73

(1.63%)

Total Assets Summary of Collegium Pharmaceutical, Inc.

  • Collegium Pharmaceutical, Inc.'s latest annual total assets in 2023 was 1.14 Billion USD , down -2.63% from previous year.
  • Collegium Pharmaceutical, Inc.'s latest quarterly total assets in 2024 Q1 was 1.11 Billion USD , down -2.54% from previous quarter.
  • Collegium Pharmaceutical, Inc. reported annual total assets of 1.17 Billion USD in 2022, up 69.65% from previous year.
  • Collegium Pharmaceutical, Inc. reported annual total assets of 692.07 Million USD in 2021, up 7.49% from previous year.
  • Collegium Pharmaceutical, Inc. reported quarterly total assets of 1.11 Billion USD for 2024 Q1, down -2.54% from previous quarter.
  • Collegium Pharmaceutical, Inc. reported quarterly total assets of 1.14 Billion USD for 2023 Q4, down -2.91% from previous quarter.

Annual Total Assets Chart of Collegium Pharmaceutical, Inc. (2023 - 2013)

Historical Annual Total Assets of Collegium Pharmaceutical, Inc. (2023 - 2013)

Year Total Assets Total Assets Growth
2023 1.14 Billion USD -2.63%
2022 1.17 Billion USD 69.65%
2021 692.07 Million USD 7.49%
2020 643.84 Million USD 110.2%
2019 306.3 Million USD 5.17%
2018 291.24 Million USD 114.83%
2017 135.56 Million USD -16.32%
2016 162.01 Million USD 65.8%
2015 97.71 Million USD 1819.8%
2014 5.09 Million USD -43.66%
2013 9.03 Million USD 0.0%

Peer Total Assets Comparison of Collegium Pharmaceutical, Inc.

Name Total Assets Total Assets Difference
Embecta Corp. 1.21 Billion USD 5.854%
ANI Pharmaceuticals, Inc. 904.42 Million USD -26.413%
Dynavax Technologies Corporation 997.09 Million USD -14.664%
Esperion Therapeutics, Inc. 205.79 Million USD -455.554%
Pacira BioSciences, Inc. 1.57 Billion USD 27.381%
PainReform Ltd. 9.93 Million USD -11413.676%
Aquestive Therapeutics, Inc. 57.41 Million USD -1891.201%
Sunshine Biopharma, Inc. 27.34 Million USD -4080.75%
SCYNEXIS, Inc. 128.41 Million USD -790.344%
China SXT Pharmaceuticals, Inc. 23.12 Million USD -4843.595%
Cosmos Health Inc. 66.29 Million USD -1624.562%
Journey Medical Corporation 76.84 Million USD -1387.733%
Sunshine Biopharma, Inc. 27.34 Million USD -4080.75%
Safety Shot Inc 12.7 Million USD -8895.923%
Alpha Teknova, Inc. 128.58 Million USD -789.132%
Intra-Cellular Therapies, Inc. 728.29 Million USD -56.984%
Bright Green Corporation 17.4 Million USD -6469.585%
Procaps Group, S.A. 460.18 Million USD -148.444%
Theratechnologies Inc. 77.76 Million USD -1370.133%
Harrow Health, Inc. 311.75 Million USD -266.733%
Sonoma Pharmaceuticals, Inc. 14.89 Million USD -7576.815%
Biofrontera Inc. 27.93 Million USD -3993.183%
DURECT Corporation 45.18 Million USD -2430.058%
Supernus Pharmaceuticals, Inc. 1.4 Billion USD 18.855%
Cronos Group Inc. 1.13 Billion USD -0.798%
OptiNose, Inc. 107.72 Million USD -961.282%
Ironwood Pharmaceuticals, Inc. 471.07 Million USD -142.703%
Kala Pharmaceuticals, Inc. 55.94 Million USD -1943.482%
RedHill Biopharma Ltd. 23.04 Million USD -4860.738%
Organogenesis Holdings Inc. 460.02 Million USD -148.532%
Guardion Health Sciences, Inc. 11.91 Million USD -9492.977%
Cumberland Pharmaceuticals Inc. 81.77 Million USD -1298.096%
Radius Health, Inc. 1.71 Billion USD 33.372%
Universe Pharmaceuticals INC 53.28 Million USD -2045.565%
ProPhase Labs, Inc. 91.92 Million USD -1143.713%
Phibro Animal Health Corporation 982.18 Million USD -16.405%
Procaps Group S.A. 460.18 Million USD -148.444%
Alvotech 950.09 Million USD -20.337%
TherapeuticsMD, Inc. 43.3 Million USD -2539.885%
Viatris Inc. 47.68 Billion USD 97.602%
Rockwell Medical, Inc. 52.17 Million USD -2091.379%
Aytu BioPharma, Inc. 118.09 Million USD -868.126%
SIGA Technologies, Inc. 254.83 Million USD -348.644%
Tilray Brands, Inc. 4.33 Billion USD 73.628%
Lifecore Biomedical, Inc. 273.7 Million USD -317.72%
Shineco, Inc. 84.17 Million USD -1258.181%
PetIQ, Inc. 868.22 Million USD -31.683%
Regencell Bioscience Holdings Limited 8.43 Million USD -13449.175%
Incannex Healthcare Limited 17.04 Million USD -6606.799%
Neurocrine Biosciences, Inc. 3.25 Billion USD 64.836%
Alimera Sciences, Inc. 153.52 Million USD -644.71%
Silver Spike Investment Corp. 88.57 Million USD -1190.761%
Assertio Holdings, Inc. 286.41 Million USD -299.173%
Shuttle Pharmaceuticals Holdings, Inc. 5.95 Million USD -19109.656%
Petros Pharmaceuticals, Inc. 33.79 Million USD -3282.989%
Clever Leaves Holdings Inc. 31.24 Million USD -3559.405%
Cyclo Therapeutics, Inc. 13.24 Million USD -8530.343%
Avadel Pharmaceuticals plc 261.12 Million USD -337.838%
Hempacco Co., Inc. 18.04 Million USD -6236.546%
Talphera, Inc. 20.39 Million USD -5505.825%
Alvotech 950.09 Million USD -20.337%
Eagle Pharmaceuticals, Inc. 406.16 Million USD -181.492%
Lantheus Holdings, Inc. 1.65 Billion USD 30.757%
Currenc Group, Inc. 141.49 Million USD -708.046%
Kamada Ltd. 351.96 Million USD -224.831%
Indivior PLC 1.95 Billion USD 41.406%
Evoke Pharma, Inc. 7.06 Million USD -16074.585%
Flora Growth Corp. 23.62 Million USD -4739.194%
Cyclo Therapeutics, Inc. 13.24 Million USD -8530.343%
Evolus, Inc. 188.99 Million USD -504.931%
HUTCHMED (China) Limited 1.27 Billion USD 10.663%
Amphastar Pharmaceuticals, Inc. 1.51 Billion USD 24.43%
Akanda Corp. 8.83 Million USD -12833.359%